Brant C. Boren

1.2k total citations · 1 hit paper
6 papers, 1.0k citations indexed

About

Brant C. Boren is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Brant C. Boren has authored 6 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Molecular Biology and 1 paper in Infectious Diseases. Recurrent topics in Brant C. Boren's work include Click Chemistry and Applications (3 papers), Catalytic Alkyne Reactions (2 papers) and Chemical Synthesis and Analysis (2 papers). Brant C. Boren is often cited by papers focused on Click Chemistry and Applications (3 papers), Catalytic Alkyne Reactions (2 papers) and Chemical Synthesis and Analysis (2 papers). Brant C. Boren collaborates with scholars based in United States and Hong Kong. Brant C. Boren's co-authors include Lars K. Rasmussen, Valery V. Fokin, Sridhar Narayan, Haitao Zhao, Zhenyang Lin, Guochen Jia, Li Zhang, Jennifer S. Hirschi, Daniel A. Singleton and Gary A. Sulikowski and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Brant C. Boren

6 papers receiving 995 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ruthenium-Catalyzed Azide−Alkyne Cycloaddition: Scope and Mechanism

2008 696 citations Brant C. Boren, Sridhar Narayan et al. Journal of the American Chemical Society profile →

Peers

Countries citing papers authored by Brant C. Boren

Since Specialization

Citations

This map shows the geographic impact of Brant C. Boren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brant C. Boren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brant C. Boren more than expected).

Fields of papers citing papers by Brant C. Boren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brant C. Boren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brant C. Boren. The network helps show where Brant C. Boren may publish in the future.

Co-authorship network of co-authors of Brant C. Boren

This figure shows the co-authorship network connecting the top 25 collaborators of Brant C. Boren. A scholar is included among the top collaborators of Brant C. Boren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brant C. Boren. Brant C. Boren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Abstract 2606: ZN-c3, a potent and selective Wee-1 inhibitor demonstrates anti-tumor activities in combination with other targeted therapies and overcomes PARP inhibitor resistance 2022 ·Cancer Research ·Jiali Li, (unknown), Petrus R. de Jong, Hooman Izadi, (unknown), (unknown), Brant C. Boren, (unknown), Fernando Doñate, Ahmed A. Samatar	2
2	Abstract 2591: Combination of the BCL-2 inhibitor ZN-d5 with the WEE1 inhibitor ZN-c3 shows additive or synergistic anti-tumor activity in acute myeloid leukemia (AML) models 2022 ·Cancer Research ·Hooman Izadi, (unknown), (unknown), (unknown), Brant C. Boren, (unknown), Petrus R. de Jong, Jiali Li, Kevin D. Bunker, Ahmed A. Samatar, Fernando Doñate	1
3	Ruthenium-Catalyzed Azide−Alkyne Cycloaddition: Scope and Mechanism 2008 ·Journal of the American Chemical Society ·Brant C. Boren, Sridhar Narayan, Lars K. Rasmussen, Li Zhang, Haitao Zhao, Zhenyang Lin, Guochen Jia, Valery V. Fokin	16
4	Ruthenium-Catalyzed Azide−Alkyne Cycloaddition: Scope and Mechanism breakdown → 2008 ·Journal of the American Chemical Society ·Brant C. Boren, Sridhar Narayan, Lars K. Rasmussen, Li Zhang, Haitao Zhao, Zhenyang Lin, Guochen Jia, Valery V. Fokin	696
5	Ruthenium-Catalyzed Cycloaddition of Aryl Azides and Alkynes 2007 ·Organic Letters ·Lars K. Rasmussen, Brant C. Boren, Valery V. Fokin	271
6	Exo-Selective Diels−Alder Reactions of Vinylazepines. Origin of Divergent Stereoselectivity in Diels−Alder Reactions of Vinylazepines, Vinylpiperideines, and Vinylcycloalkenes 2003 ·The Journal of Organic Chemistry ·Brant C. Boren, Jennifer S. Hirschi, Joseph H. Reibenspies, (unknown), Daniel A. Singleton, Gary A. Sulikowski	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact